Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $44 Million - $60.5 Million
-487,400 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $37.4 Million - $55.6 Million
-399,540 Reduced 45.05%
487,400 $60.6 Million
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $32.2 Million - $42.8 Million
275,839 Added 45.14%
886,940 $117 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $60.9 Million - $86.8 Million
611,101 New
611,101 $81 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.48B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.